Glycogen synthase kinase-3β genetic polymorphisms and insomnia in depressed patients: A prospective study-Reference-Cited by-同舟云学术

Glycogen synthase kinase-3β genetic polymorphisms and insomnia in depressed patients: A prospective study

Published:2018-11 Issue: Volume:240 Page:230-236
ISSN:0165-0327
Container-title:Journal of Affective Disorders
language:en
Short-container-title:Journal of Affective Disorders

Author:

Costemale-Lacoste Jean-François,Colle Romain,Martin Séverine,Asmar Khalil El,Loeb Emanuel,Feve Bruno,Verstuyft Céline,Trabado Séverine,Ferreri Florian,Haffen Emmanuel^ORCID,Polosan Mircea,Becquemont Laurent,Corruble Emmanuelle

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,Clinical Psychology

Reference54 articles.

1. The bipolarity of light and dark: a review on bipolar disorder and circadian cycles;Abreu;J. Affect. Disord.,2015

2. Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta -50T/C single nucleotide polymorphism;Adli;Biol. Psychiatry,2007

3. Insomnia and somnolence associated with second-generation antidepressants during the treatment of major depression: a meta-analysis;Alberti;J. Clin. Psychopharmacol.,2015

4. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade;Beaulieu;Proc. Natl. Acad. Sci. USA,2004

5. Akt/GSK3 signaling in the action of psychotropic drugs;Beaulieu;Annu Rev Pharmacol Toxicol,2009

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In silico analysis of the effects of non-synonymous SNPs associated with human GSK3B gene on its structure and function;Human Gene;2024-12

2. Circadian markers as a predictor of response in the treatment of depression–A systematic review;Psychiatry Research;2024-08

3. Potential genetic and epigenetic mechanisms in insomnia: A systematic review;Journal of Sleep Research;2023-03-14

4. Molecular targets and mechanisms involved in the action of Banxia Shumi decoction in insomnia treatment;Medicine;2023-03-10

5. Glycogen Synthase Kinase-3 Inhibitors: Preclinical and Clinical Focus on CNS-A Decade Onward;Frontiers in Molecular Neuroscience;2022-01-21